Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

108 Results

Document

Esophageal Cancer Treatment Pathway Map

May 2019

Guidelines and Advice

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Status: Archived
ID: 12-6

May 2012

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Enhancing the Delivery of Oncology Systemic Treatment in the Home and Community in Ontario Recommendations Report

Status: Current
Version: 1

Feb 2022

Guidelines and Advice

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

Status: Current
ID: GL-C50-29

Mar 2012

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Status: In-Review
ID: 7-14
Version: 3

Dec 2018

Guidelines and Advice

Epirubicin, as a Single Agent or in Combination, for Metastatic Breast Cancer

Status: Archived
ID: 1-6

Sep 2011

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Symptom Management

Urinary Incontinence - Prostate Cancer

Symptom Management

Urinary Problems - Prostate Cancer

Guidelines and Advice

Use of Strontium 89 in Patients with Endocrine-Refractory Carcinoma of the Prostate Metastatic to Bone

Status: Archived
ID: 3-6

Nov 2011

Pages